West Pharmaceutical Services | WST - Ordinary Share Capital


West Pharmaceutical Services reported $70.4M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Align Technology USD 71.04M 578K Sep/2026
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Cooper Companies USD 190.1M 5.01M Jun/2026
Dentsply International USD 199.2M 1.1M Jun/2026
Haemonetics USD 45.47M 1.36M Jun/2026
ICU Medical USD 24.99M 305K Mar/2026
Insulet USD 69.35M 87K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
J&J USD 2.41B 1.64M Jun/2026
Medtronic USD 1.28B 130K Jun/2026
Merit Medical Systems USD 59.71M 55K Jun/2026
Neogen USD 218.3M 600K Jun/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 68.1M 200K Mar/2026
Repligen USD 56.69M 266K Sep/2026
Solventum Corp USD 170.11M 3.42M Jun/2026
STAAR Surgical USD 50.12M 343K Jun/2026
Terumo JPY 1.48B 19K Jun/2026
Utah Medical Products USD 3.18M 2K Mar/2026
West Pharmaceutical Services USD 70.4M 500K Jun/2026